Vaccine Watch: European Union gives emergency approval to Moderna COVID-19 vaccine

The vaccine makes use of the mRNA platform like Pfizer’s vaccine, which the EU has already approved for emergency use  

Bizarre patent tussles over a COVID-19 jab

Moderna’s many intellectual property disputes over its vaccine highlight the need for a patent-free regime to fight the pandemic

Moderna claims 94% efficacy for its COVID-19 vaccine, to seek emergency nod

No Indian partner yet for production or distribution; results not final

Bharat Biotech COVID-19 vaccine claimed to have 80.6% efficacy

'Shot well tolerated in participants; adverse events balanced between vaccine and placebo arms of the trial'    

COVID-19 vaccines: Is foreign good for India

The decision to allow foreign vaccines in India may not take plug the current shortage  

How drug companies are sidestepping the WHO’s technology transfer hub in Africa

The actions of BioNTech and Moderna will prolong the social and economic costs of the pandemic

Pfizer wants to sell vaccines in India at no profit

The Pfizer vaccine is yet to be registered in India although it had applied months ago

India readies for COVID-19 vaccination but vexed questions on the solution remain

The risks the country needs to prepare for, precautions it needs to take, the logistics required and, above all, the implications of it all for …

Update COVID-19 vaccine to target omicron variants: Advisory panel to USFDA

Unclear which combination of updated vaccine will work best; body expected to decide by July

COVID-19: J&J vaccine can heighten risk of rare neurological condition

The Guillain-Barré syndrome can cause muscle weakness and paralysis.

COVID-19 Vaccine Watch: India tops number of COVID-19 vaccine doses arranged from manufacturers

However, in terms of the proportion of the population that can be vaccinated with these doses, Canada leads the charts

WATCH: Will mixing COVID-19 vaccines be effective?

Some early studies have shown that combining vaccines produce a better immune response. But the efficacy of the vaccine combination is yet to be …

COVID-19 vaccines for all: Decoding global tenders by states

At least a dozen Indian states have floated or will float tenders for procuring vaccines and will also bear the cost

COVID-19 vaccines: How Pfizer and Moderna’s 95% effective mRNA shots work

Should we expect the pandemic to be over once a vaccine is available for public use? Not exactly. A vaccine will not be perfect, and it takes …

Moderna’s COVID vaccine reports 95% efficacy. It means we might have multiple successful vaccines

It opens the door to the possibility we might have many successful vaccines, and be able to tailor different vaccines to people with different needs

Covaxin effective against UK Strain: What does this mean in absence of efficacy data?

Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts

WTO decision on access to COVID-19 drugs without strings delayed

Proposal will be formally discussed in March next year, sources say

COVID-19 vaccine: Oxford-AstraZeneca up to 90% effective in late stage trial

Adenovirus vaccine can be stored at 2-8°C; company to apply for emergency authorisation

Experts suggest updating vaccines for new variants. How does it work & what are the challenges?

It is easier to update certain vaccine platforms than others, say experts

COVID-19 Challenge 2021: How does the world overcome vaccine shortage

The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …

What COVID-19 vaccine side effects might I expect?

In the vast majority of cases, any side effect you feel will be over within a few days, and there is no reason for concern

UK, South African, Brazilian: A virologist explains each COVID-19 variant, what they mean for the pandemic

The take-home message is that variants will emerge, and we need to closely monitor their spread

Moderna’s COVID-19 breakthrough: Is the media hype justified

The biotech firm develops vaccine against novel coronavirus disease that shows positive results for eight patients

Coronavirus vaccines: TRIPS waiver caught in WTO labyrinth

Little change in the position of countries opposing waiver of intellectual property rights; India-South Africa proposal being through hoops …

COVID-19 vaccine development: It’s a relay race

The reason trials are taking shorter time is because developers are taking more risks